Pioglitazone for NAFLD Patients With Prediabetes or Type 2 Diabetes Mellitus: A Meta-Analysis
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Pioglitazone for NAFLD Patients With Prediabetes or Type 2 Diabetes Mellitus: A Meta-Analysis
Authors
Keywords
-
Journal
Frontiers in Endocrinology
Volume 12, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2021-04-29
DOI
10.3389/fendo.2021.615409
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Beneficial effect of anti-diabetic drugs for nonalcoholic fatty liver disease
- (2020) Kyung-Soo Kim et al. Clinical and Molecular Hepatology
- Role of Vitamin E for Nonalcoholic Steatohepatitis in Patients With Type 2 Diabetes: A Randomized Controlled Trial
- (2019) Fernando Bril et al. DIABETES CARE
- The Global Epidemiology of NAFLD and NASH in Patients with type 2 diabetes: A Systematic Review and Meta-analysis
- (2019) Zobair M. Younossi et al. JOURNAL OF HEPATOLOGY
- NAFLD and Diabetes: Two Sides of the Same Coin? Rationale for Gene-Based Personalized NAFLD Treatment
- (2019) Ming-Feng Xia et al. Frontiers in Pharmacology
- Trends in pioglitazone use among U.S. adults with type 2 diabetes and suspected nonalcoholic fatty liver disease
- (2019) Phuc Le et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Non-alcoholic Steatohepatitis is the Fastest Growing Cause of Hepatocellular Carcinoma in Liver Transplant Candidates
- (2018) Zobair Younossi et al. Clinical Gastroenterology and Hepatology
- European Association for the Study of the Liver (EASL), European Association for the Study of Diabetes (EASD) and European Association for the Study of Obesity (EASO) clinical practice recommendations for the management of non-alcoholic fatty liver diseas
- (2018) A. L. Sberna et al. DIABETIC MEDICINE
- Thiazolidinediones and Advanced Liver Fibrosis in Nonalcoholic Steatohepatitis
- (2017) Giovanni Musso et al. JAMA Internal Medicine
- Long-Term Pioglitazone Treatment for Patients With Nonalcoholic Steatohepatitis and Prediabetes or Type 2 Diabetes Mellitus
- (2016) Kenneth Cusi et al. ANNALS OF INTERNAL MEDICINE
- EASL–EASD–EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease
- (2016) et al. DIABETOLOGIA
- Thiazolidinediones for nonalcoholic steatohepatitis
- (2016) Lingling He et al. MEDICINE
- Non-alcoholic fatty liver disease (NAFLD): summary of NICE guidance
- (2016) Jessica Glen et al. BMJ-British Medical Journal
- Non-alcoholic fatty liver disease (NAFLD): summary of NICE guidance
- (2016) Jessica Glen et al. BMJ-British Medical Journal
- Comparative effectiveness of pharmacological interventions for nonalcoholic steatohepatitis: A systematic review and network meta-analysis
- (2015) Siddharth Singh et al. HEPATOLOGY
- Challenges and opportunities in drug and biomarker development for nonalcoholic steatohepatitis: Findings and recommendations from an American Association for the Study of Liver Diseases-U.S. Food and Drug Administration Joint Workshop
- (2015) Arun J. Sanyal et al. HEPATOLOGY
- High Prevalence of Nonalcoholic Fatty Liver Disease in Patients With Type 2 Diabetes Mellitus and Normal Plasma Aminotransferase Levels
- (2015) Paola Portillo-Sanchez et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- NAFLD: A multisystem disease
- (2015) Christopher D. Byrne et al. JOURNAL OF HEPATOLOGY
- Efficacy of Berberine in Patients with Non-Alcoholic Fatty Liver Disease
- (2015) Hong-Mei Yan et al. PLoS One
- The role of liver fat and insulin resistance as determinants of plasma aminotransferase elevation in nonalcoholic fatty liver disease
- (2014) Maryann Maximos et al. HEPATOLOGY
- Predictors of All-Cause Mortality and Liver-Related Mortality in Patients with Non-Alcoholic Fatty Liver Disease (NAFLD)
- (2013) Maria Stepanova et al. DIGESTIVE DISEASES AND SCIENCES
- Prevalence of and Risk Factors for Hepatic Steatosis and Nonalcoholic Fatty Liver Disease in People With Type 2 Diabetes: the Edinburgh Type 2 Diabetes Study
- (2011) R. M. Williamson et al. DIABETES CARE
- Effects of intensive insulin therapy alone and in combination with pioglitazone on body weight, composition, distribution and liver fat content in patients with type 2 diabetes
- (2011) P. K. Shah et al. DIABETES OBESITY & METABOLISM
- Histopathological stages of nonalcoholic fatty liver disease in type 2 diabetes: prevalences and correlated factors
- (2011) Nathalie C. Leite et al. LIVER INTERNATIONAL
- A meta-analysis of randomized trials for the treatment of nonalcoholic fatty liver disease
- (2010) Giovanni Musso et al. HEPATOLOGY
- Prevalence and associated factors of non-alcoholic fatty liver disease in patients with type-2 diabetes mellitus
- (2010) Nathalie C. Leite et al. LIVER INTERNATIONAL
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started